酸化再生セルロースベースの止血材市場：エンドユーザー別、流通チャネル別-2025-2030年の世界予測

酸化再生セルロースベースの止血材市場は、2023年に1億8,263万米ドルと評価され、2024年には2億507万米ドルに達すると予測され、CAGR 12.38%で成長し、2030年には4億1,345万米ドルに達すると予測されています。

酸化再生セルロース（ORC）ベースの止血材は、主に外科手術中の出血を抑えるために使用される重要な生体吸収性材料です。これらの止血材は、迅速な止血作用と生体適合性により好まれており、迅速な血液凝固が必要な手術への応用に不可欠です。これには、心臓血管外科、整形外科、一般外科での用途が含まれます。最終用途は病院、専門クリニック、外来手術センターなど多岐にわたる。ORCベースの止血材の市場成長は、主に外科手術の増加、高度な外科製品に関する意識の高まり、手術合併症を最小限に抑える必要性によってもたらされます。さらに、止血材の技術進歩や低侵襲手術の採用拡大も主要な成長要因です。しかし、厳しい規制要件、高コスト、特定の患者における炎症反応の可能性などの要因により、市場の拡大は制限される可能性があります。とはいえ、生体適合性を高めるための研究が進んでおり、複合止血材（ORCと他の材料を組み合わせたもの）の開発には有利な機会があります。企業は、ヘルスケア・プロバイダーとの戦略的パートナーシップを重視して製品範囲を拡大し、R&Dに投資して外傷治療や軍事医療介入など、より広範な用途でイノベーションを起こすことが推奨されます。また、手術中のコントロールと精度を高める生分解性ORC製剤の探求も、大きな競争力をもたらす可能性があります。この市場に参入または拡大する企業にとっては、コンプライアンスを通じて規制上のハードルを克服し、患者の転帰の改善を実証することで市場の信頼を得ることに重点を置くべきです。さらに、急成長しているヘルスケア市場、特に新興国におけるアンメットニーズを特定することで、大きな成長機会がもたらされる可能性があります。市場の競争は依然として激しいが、将来性は高く、継続的な技術革新と多機能止血ソリューションの重視の高まりが今後の成長を牽引するものと思われます。

市場力学：急速に進化する酸化再生セルロースベースの止血材市場の主要市場インサイトを公開

酸化再生セルロースベースの止血材市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 手術創を管理するための事前ケアの必要性
  • 高齢化人口の急増
  • 患者の安全確保と早期回復の必要性
  • セルロース系止血材の手頃な価格の高さ
• 市場抑制要因
  • 新製品に対する開業医の消極性
  • 魅力的な代替品の存在
• 市場機会
  • 改良型止血材の継続的な研究開発
  • 新興国における需要の増加
• 市場の課題
  • 患者の感受性の問題

ポーターの5つの力酸化再生セルロースベースの止血材市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：酸化再生セルロースベースの止血材市場における外部からの影響の把握

外部マクロ環境要因は、酸化再生セルロースベースの止血材市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析酸化再生セルロースベースの止血材市場における競合情勢の把握

酸化再生セルロースベースの止血材市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス酸化再生セルロースベースの止血材市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、酸化再生セルロースベースの止血材市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨酸化再生セルロースベースの止血材市場における成功への道筋を描く

酸化再生セルロースベースの止血材市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 手術創の管理には事前ケアが必要
    • 高齢化人口の急速な増加
    • 患者の安全を確保し、迅速な回復を図る必要がある
    • セルロース系止血材の手頃な価格
  • 抑制要因
    • 新製品に対する実践者の消極的な態度
    • 魅力的な代替品の入手可能性
  • 機会
    • 改良された止血剤の継続的な研究開発
    • 新興国における需要の増加
  • 課題
    • 患者の感受性の問題
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 酸化再生セルロースベースの止血材市場：エンドユーザー別

• クリニック
• 感染症

第7章 酸化再生セルロースベースの止血材市場：流通チャネル別

• 直接販売
• 小売販売

第8章 南北アメリカの酸化再生セルロースベースの止血材市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の酸化再生セルロースベースの止血材市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの酸化再生セルロースベースの止血材市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Aegis Lifesciences
• Altaylar Medical
• B. Braun SE
• Betatech Medical
• CuraMedical B.V.
• GELITA MEDICAL GmbH
• Hangzhou Singclean Medical Products Co., Ltd.
• Healthium Medtech Limited
• Johnson & Johnson Services, Inc.
• Meril Life Sciences Pvt. Ltd.
• Synthesia, a.s.

LIST OF FIGURES

• FIGURE 1. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET RESEARCH PROCESS
• FIGURE 2. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET DYNAMICS
• TABLE 7. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY CLINIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY RETAIL SALES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 14. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 16. ARGENTINA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 17. ARGENTINA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 18. BRAZIL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 19. BRAZIL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 20. CANADA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 21. CANADA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 22. MEXICO OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 23. MEXICO OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 24. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 25. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 27. ASIA-PACIFIC OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 28. ASIA-PACIFIC OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 30. AUSTRALIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 31. AUSTRALIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 32. CHINA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 33. CHINA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 34. INDIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 35. INDIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 36. INDONESIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 37. INDONESIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 38. JAPAN OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 39. JAPAN OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 40. MALAYSIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 41. MALAYSIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 42. PHILIPPINES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 43. PHILIPPINES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 44. SINGAPORE OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 45. SINGAPORE OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 46. SOUTH KOREA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 47. SOUTH KOREA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 48. TAIWAN OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 49. TAIWAN OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 50. THAILAND OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 51. THAILAND OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 52. VIETNAM OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 53. VIETNAM OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 54. EUROPE, MIDDLE EAST & AFRICA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. EUROPE, MIDDLE EAST & AFRICA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 57. DENMARK OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 58. DENMARK OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 59. EGYPT OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 60. EGYPT OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 61. FINLAND OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 62. FINLAND OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 63. FRANCE OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64. FRANCE OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 65. GERMANY OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 66. GERMANY OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 67. ISRAEL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 68. ISRAEL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 69. ITALY OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. ITALY OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 71. NETHERLANDS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 72. NETHERLANDS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 73. NIGERIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 74. NIGERIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 75. NORWAY OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 76. NORWAY OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 77. POLAND OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 78. POLAND OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 79. QATAR OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80. QATAR OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 81. RUSSIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 82. RUSSIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 83. SAUDI ARABIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 84. SAUDI ARABIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH AFRICA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH AFRICA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 87. SPAIN OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 88. SPAIN OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 89. SWEDEN OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. SWEDEN OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 91. SWITZERLAND OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. SWITZERLAND OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 93. TURKEY OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 94. TURKEY OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 95. UNITED ARAB EMIRATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 96. UNITED ARAB EMIRATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 97. UNITED KINGDOM OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 98. UNITED KINGDOM OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 99. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 100. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET, FPNV POSITIONING MATRIX, 2023

The Oxidized Regenerated Cellulose Based Hemostats Market was valued at USD 182.63 million in 2023, expected to reach USD 205.07 million in 2024, and is projected to grow at a CAGR of 12.38%, to USD 413.45 million by 2030.

Oxidized Regenerated Cellulose (ORC) based hemostats are crucial bioresorbable materials primarily used to control bleeding during surgical procedures. These hemostats are favored for their quick hemostatic action and biocompatibility, making them essential for applications in surgeries where rapid blood coagulation is required. This includes applications in cardiovascular, orthopedic, and general surgeries. The end-use scope spans across hospitals, specialty clinics, and ambulatory surgical centers. The market growth for ORC-based hemostats is primarily driven by the increasing number of surgical procedures, rising awareness about advanced surgical products, and the need for minimizing operative complications. Additionally, technological advancements in hemostatic materials and the growing adoption of minimally invasive surgeries are key growth factors. However, the market's expansion could be limited by factors such as strict regulatory requirements, high costs, and the potential for inflammatory responses in certain patients. Nevertheless, ongoing research into enhancing biocompatibility and the development of composite hemostatic agents (combining ORC with other materials) present lucrative opportunities. Companies are recommended to focus on strategic partnerships with healthcare providers to expand product reach and invest in R&D to innovate with broader applications, such as in trauma care and military medical interventions. Exploring biodegradable ORC formulations that offer more control and precision during surgery could also present a significant competitive edge. For a business entering or expanding in this market, the focus should be on overcoming regulatory hurdles through compliance and gaining market trust by demonstrating improved patient outcomes. Furthermore, identifying unmet needs in rapidly growing healthcare markets, particularly in emerging economies, could offer substantial growth opportunities. The nature of the market remains competitive yet promising, with ongoing innovation and an increasing emphasis on multi-functional hemostatic solutions poised to drive future growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Oxidized Regenerated Cellulose Based Hemostats Market

The Oxidized Regenerated Cellulose Based Hemostats Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Need for advance care to manage surgical wounds
  • Rapid growth in the aging population
  • Need to ensure patient safety and render rapid recovery
  • High affordability of cellulose-based hemostats
• Market Restraints
  • Reluctance of practitioners towards new products
  • Availability of attractive substitutes
• Market Opportunities
  • Ongoing research and development of improved hemostats
  • Increasing demand in emerging economies
• Market Challenges
  • Patient sensitivity issues

Porter's Five Forces: A Strategic Tool for Navigating the Oxidized Regenerated Cellulose Based Hemostats Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Oxidized Regenerated Cellulose Based Hemostats Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Oxidized Regenerated Cellulose Based Hemostats Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Oxidized Regenerated Cellulose Based Hemostats Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Oxidized Regenerated Cellulose Based Hemostats Market

A detailed market share analysis in the Oxidized Regenerated Cellulose Based Hemostats Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Oxidized Regenerated Cellulose Based Hemostats Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Oxidized Regenerated Cellulose Based Hemostats Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Oxidized Regenerated Cellulose Based Hemostats Market

A strategic analysis of the Oxidized Regenerated Cellulose Based Hemostats Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Oxidized Regenerated Cellulose Based Hemostats Market, highlighting leading vendors and their innovative profiles. These include Aegis Lifesciences, Altaylar Medical, B. Braun SE, Betatech Medical, CuraMedical B.V., GELITA MEDICAL GmbH, Hangzhou Singclean Medical Products Co., Ltd., Healthium Medtech Limited, Johnson & Johnson Services, Inc., Meril Life Sciences Pvt. Ltd., and Synthesia, a.s..

Market Segmentation & Coverage

This research report categorizes the Oxidized Regenerated Cellulose Based Hemostats Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on End User, market is studied across Clinic and Infectious Diseases.
• Based on Distribution Channel, market is studied across Direct Sales and Retail Sales.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Need for advance care to manage surgical wounds
    • 5.1.1.2. Rapid growth in the aging population
    • 5.1.1.3. Need to ensure patient safety and render rapid recovery
    • 5.1.1.4. High affordability of cellulose-based hemostats
  • 5.1.2. Restraints
    • 5.1.2.1. Reluctance of practitioners towards new products
    • 5.1.2.2. Availability of attractive substitutes
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing research and development of improved hemostats
    • 5.1.3.2. Increasing demand in emerging economies
  • 5.1.4. Challenges
    • 5.1.4.1. Patient sensitivity issues
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Oxidized Regenerated Cellulose Based Hemostats Market, by End User

• 6.1. Introduction
• 6.2. Clinic
• 6.3. Infectious Diseases

7. Oxidized Regenerated Cellulose Based Hemostats Market, by Distribution Channel

• 7.1. Introduction
• 7.2. Direct Sales
• 7.3. Retail Sales

8. Americas Oxidized Regenerated Cellulose Based Hemostats Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Oxidized Regenerated Cellulose Based Hemostats Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Oxidized Regenerated Cellulose Based Hemostats Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Aegis Lifesciences
• 2. Altaylar Medical
• 3. B. Braun SE
• 4. Betatech Medical
• 5. CuraMedical B.V.
• 6. GELITA MEDICAL GmbH
• 7. Hangzhou Singclean Medical Products Co., Ltd.
• 8. Healthium Medtech Limited
• 9. Johnson & Johnson Services, Inc.
• 10. Meril Life Sciences Pvt. Ltd.
• 11. Synthesia, a.s.